Mohammed A. Aljama

540 citations
33 papers · 252 indexed · h-index 8
Topics
Multiple Myeloma Research and Treatments (18 papers)Chronic Lymphocytic Leukemia Research (8 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers)

In The Last Decade

Mohammed A. Aljama

30 papers receiving 249 citations

Peers

Mohammed A. Aljama
Comparison fields: 5 of 39
  • Molecular Biology 165
  • Hematology 102
  • Oncology 90
  • Epidemiology 75
  • Genetics 64
Replace Nancy Bello with:
Nancy Bello United States
Sossana Delimpasi Greece
Nobuya Hiraoka Japan
Robert Greiner United States
Rossana Putzulu Italy
Ami Patel United States
Zonghong Shao China
Anthony C Shelton United States
Shuichi Shirane Japan
Toshikazu Akioka Japan
Mohammed A. Aljama relative to Nancy Bello United States Nancy Bello's profile →
Citations per field
00.5×5.3×
Nancy Bello · 1×
Citations per year

Countries citing papers authored by Mohammed A. Aljama

Since Specialization
Citations

This map shows the geographic impact of Mohammed A. Aljama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed A. Aljama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed A. Aljama more than expected).

Fields of papers citing papers by Mohammed A. Aljama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed A. Aljama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed A. Aljama. The network helps show where Mohammed A. Aljama may publish in the future.

Co-authorship network of co-authors of Mohammed A. Aljama

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed A. Aljama. A scholar is included among the top collaborators of Mohammed A. Aljama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed A. Aljama. Mohammed A. Aljama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 0
5 1
6 1
7 7
8 1
9 2
10 2
11 19
12 1
13 9
14 3
15 8
16 5
17 7
18 2
19 5
20 9

About Mohammed A. Aljama

Mohammed A. Aljama is a scholar working on Hematology, Genetics and Family Practice, having authored 33 papers that have together received 252 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers). The work is most often cited by research in Hematology (102 citations), Genetics (64 citations) and Oncology (90 citations). Mohammed A. Aljama has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include M Hasib Sidiqi, Morie A. Gertz, David Dingli, Hagen F. Kennecke, Shaji Kumar, William J. Hogan, Prashant Kapoor, Martha Q. Lacy, Rahma Warsame and Wilson I. Gonsalves. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026